Get Real Time Here
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ:MIST), Quotes and News Summary
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
| Open3.080 | Close3.100 |
| Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
| Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.390 | -0.370 | 0.0200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
| 2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
| 2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
| 2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
How do I buy Milestone Pharmaceuticals (MIST) stock?
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Who are Milestone Pharmaceuticals's (MIST) competitors?
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
Current Stock Price for Milestone Pharmaceuticals (MIST)?
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
Does Milestone Pharmaceuticals (MIST) pay a dividend?
There is no dividend information for Milestone Pharmaceuticals.
When is Milestone Pharmaceuticals (NASDAQ:MIST) reporting earnings?
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Milestone Pharmaceuticals (MIST) going to split?
There is no upcoming split for Milestone Pharmaceuticals.
What sector and industry does Milestone Pharmaceuticals (MIST) operate in?
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.